semaglutide for thyroid Compounded Hypothyroid Can Semaglutide Cause Thyroid Issues?

Published July 7, 2022

The trial enrolled 281 participants across 42 research and healthcare centers in the United States, randomized to once-weekly subcutaneous retatrutide (0.5, 4, 8, or 12 mg), once-weekly subcutaneous dulaglutide 1.5 mg (active comparator), or placebo, over a 36-week treatment period

2023 Aug;402(10401):52944

PMID 24725840

For those researching peptides for fat loss or prescription weight loss peptides heading into 2026, understanding what telehealth platforms actually offerand what they don't guaranteeis essential before making any decisions

The Canadian study found that those who use GLP-1 agonists face a 9.09-times higher risk of pancreatitis, a 4.22-times higher risk of bowel obstruction and a 3.67-times higher risk of stomach paralysis